The global Follicular Lymphoma Treatment market was valued at US$ 1760.6 million in 2022 and is projected to reach US$ 2231.7 million by 2029, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Follicular lymphoma is a cancer that affects white blood cells called lymphocytes. There are two types of lymphomas: Hodgkin's and non-Hodgkin's, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin's lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc.
Follicular Lymphoma Treatment Market aims to provide a comprehensive presentation of the global market for Follicular Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicular Lymphoma Treatment. Follicular Lymphoma Treatment Market contains market size and forecasts of Follicular Lymphoma Treatment in global, including the following market information:
Global Follicular Lymphoma Treatment Market Revenue, 2018-2023, 20242035, ($ millions)
Global top five companies in 2022 (%)
Global core follicular lymphoma drugs players include Roche, Teva and Bayer etc. The Top3 companies hold a share about 57%. North America is the largest market, with a share about 58%, followed by Europe and Asia Pacific with the share about 21% and 20%.
We surveyed the Follicular Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Follicular Lymphoma Treatment Market, by Type, 2018-2023, 20242035 ($ millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, by Type, 2022 (%)
- Chemotherapy
- Radiotherapy
- Monoclonal Antibodies
- Stem Cell Transplantation
Global Follicular Lymphoma Treatment Market, by Application, 2018-2023, 20242035 ($ millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, by Application, 2022 (%)
Global Follicular Lymphoma Treatment Market, By Region and Country, 2018-2023, 20242035 ($ Millions)
Global Follicular Lymphoma Treatment Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Follicular Lymphoma Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Follicular Lymphoma Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Boehringer Ingelheim GmbH
- Bristol-Myers Squibb Company
- Celgene Corporation
- Celldex Therapeutics, Inc.
- Celltrion, Inc.
- Cellular Biomedicine Group, Inc.
- Coherus BioSciences, Inc.
- CTI BioPharma Corp.
- Curis, Inc.
- Dynavax Technologies Corporation
- Eisai
- EpiZyme, Inc.
- F. Hoffmann-La Roche Ltd.
- Genentech, Inc.
- Gilead Sciences, Inc.
- GlaxoSmithKline Plc
- Hutchison MediPharma Limited
- Immune Design Corp.
- ImmunoGen, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Follicular Lymphoma Treatment, market overview.
Chapter 2: Global Follicular Lymphoma Treatment market size in revenue.
Chapter 3: Detailed analysis of Follicular Lymphoma Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Follicular Lymphoma Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Industry Market Size
